BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 34767070)

  • 41. Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy.
    Fakhoury M
    Curr Neuropharmacol; 2018; 16(5):508-518. PubMed ID: 28730967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association of astrogliosis and microglial activation with aging and Alzheimer's disease pathology in the chimpanzee brain.
    Edler MK; Munger EL; Maycon H; Hopkins WD; Hof PR; Sherwood CC; Raghanti MA
    J Neurosci Res; 2023 Jun; 101(6):881-900. PubMed ID: 36647571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype.
    Sullivan MA; Lane SD; McKenzie ADJ; Ball SR; Sunde M; Neely GG; Moreno CL; Maximova A; Werry EL; Kassiou M
    J Neuroinflammation; 2024 Jan; 21(1):7. PubMed ID: 38178159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia.
    Walker DG; Whetzel AM; Lue LF
    Neuroscience; 2015 Aug; 302():121-37. PubMed ID: 25286386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer's Disease.
    Tournier BB; Tsartsalis S; Ceyzériat K; Fraser BH; Grégoire MC; Kövari E; Millet P
    J Alzheimers Dis; 2020; 77(3):1043-1056. PubMed ID: 32804124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.
    Thanopoulou K; Fragkouli A; Stylianopoulou F; Georgopoulos S
    Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20816-21. PubMed ID: 21076037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GJA1 (connexin43) is a key regulator of Alzheimer's disease pathogenesis.
    Kajiwara Y; Wang E; Wang M; Sin WC; Brennand KJ; Schadt E; Naus CC; Buxbaum J; Zhang B
    Acta Neuropathol Commun; 2018 Dec; 6(1):144. PubMed ID: 30577786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
    Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
    Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
    Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
    Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1.
    Li QS; De Muynck L
    Brain Behav Immun Health; 2021 May; 13():100227. PubMed ID: 34589742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adhesion of exogenous human microglia and THP-1 cells to amyloid plaques of postmortem Alzheimer's disease brain.
    Hashioka S; Miklossy J; Schwab C; Klegeris A; McGeer PL
    J Alzheimers Dis; 2008 Jul; 14(3):345-52. PubMed ID: 18599961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?
    von Bernhardi R; Ramirez G
    Biol Res; 2001; 34(2):123-8. PubMed ID: 11715204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer's disease brain.
    You Y; Muraoka S; Jedrychowski MP; Hu J; McQuade AK; Young-Pearse T; Aslebagh R; Shaffer SA; Gygi SP; Blurton-Jones M; Poon WW; Ikezu T
    J Extracell Vesicles; 2022 Jan; 11(1):e12183. PubMed ID: 35029059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
    Johnson ECB; Dammer EB; Duong DM; Ping L; Zhou M; Yin L; Higginbotham LA; Guajardo A; White B; Troncoso JC; Thambisetty M; Montine TJ; Lee EB; Trojanowski JQ; Beach TG; Reiman EM; Haroutunian V; Wang M; Schadt E; Zhang B; Dickson DW; Ertekin-Taner N; Golde TE; Petyuk VA; De Jager PL; Bennett DA; Wingo TS; Rangaraju S; Hajjar I; Shulman JM; Lah JJ; Levey AI; Seyfried NT
    Nat Med; 2020 May; 26(5):769-780. PubMed ID: 32284590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.
    Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S
    Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.